GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Steep Hill Inc (XCNQ:STPH) » Definitions » FCF Margin %

Steep Hill (XCNQ:STPH) FCF Margin % : 0.00% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Steep Hill FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Steep Hill's Free Cash Flow for the three months ended in Dec. 2023 was C$-0.54 Mil. Steep Hill's Revenue for the three months ended in Dec. 2023 was C$0.00 Mil. Therefore, Steep Hill's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Steep Hill's current FCF Yield % is 153.20%.

The historical rank and industry rank for Steep Hill's FCF Margin % or its related term are showing as below:


During the past 5 years, the highest FCF Margin % of Steep Hill was -154.64%. The lowest was -167.31%. And the median was -160.98%.

XCNQ:STPH's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.06
* Ranked among companies with meaningful FCF Margin % only.


Steep Hill FCF Margin % Historical Data

The historical data trend for Steep Hill's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steep Hill FCF Margin % Chart

Steep Hill Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
- - -167.31 -154.64 -

Steep Hill Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.00 - - - -

Competitive Comparison of Steep Hill's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Steep Hill's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Steep Hill's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Steep Hill's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Steep Hill's FCF Margin % falls into.



Steep Hill FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Steep Hill's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=0.742/0
= %

Steep Hill's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-0.54/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Steep Hill FCF Margin % Related Terms

Thank you for viewing the detailed overview of Steep Hill's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Steep Hill (XCNQ:STPH) Business Description

Traded in Other Exchanges
N/A
Address
120 Adelaide Street West, Suite 2500, Toronto, ON, CAN, M5H 1T1
Steep Hill Inc is a science and technology health and wellness company focused on the hemp markets inclusive of plant-based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals. Currently the company, through its subsidiaries holds three industrial hemp licences for the purposes of supplying the global market with medicinal and wellness cannabidiol and other cannabinoid-based products.

Steep Hill (XCNQ:STPH) Headlines

No Headlines